1. Home
  2. PHAT vs LVRO Comparison

PHAT vs LVRO Comparison

Compare PHAT & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • LVRO
  • Stock Information
  • Founded
  • PHAT 2018
  • LVRO 2017
  • Country
  • PHAT United States
  • LVRO Brazil
  • Employees
  • PHAT N/A
  • LVRO 3767
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • LVRO Blank Checks
  • Sector
  • PHAT Health Care
  • LVRO Finance
  • Exchange
  • PHAT Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • PHAT 539.5M
  • LVRO 584.2M
  • IPO Year
  • PHAT 2019
  • LVRO N/A
  • Fundamental
  • Price
  • PHAT $8.32
  • LVRO $5.00
  • Analyst Decision
  • PHAT Strong Buy
  • LVRO Buy
  • Analyst Count
  • PHAT 4
  • LVRO 3
  • Target Price
  • PHAT $23.00
  • LVRO $7.17
  • AVG Volume (30 Days)
  • PHAT 992.3K
  • LVRO 4.8K
  • Earning Date
  • PHAT 11-07-2024
  • LVRO 01-22-2025
  • Dividend Yield
  • PHAT N/A
  • LVRO N/A
  • EPS Growth
  • PHAT N/A
  • LVRO N/A
  • EPS
  • PHAT N/A
  • LVRO N/A
  • Revenue
  • PHAT $26,270,000.00
  • LVRO $1,691,812,087.00
  • Revenue This Year
  • PHAT $7,622.43
  • LVRO N/A
  • Revenue Next Year
  • PHAT $236.87
  • LVRO $12.53
  • P/E Ratio
  • PHAT N/A
  • LVRO N/A
  • Revenue Growth
  • PHAT N/A
  • LVRO 0.48
  • 52 Week Low
  • PHAT $6.07
  • LVRO $3.42
  • 52 Week High
  • PHAT $19.71
  • LVRO $9.00
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 36.67
  • LVRO 54.16
  • Support Level
  • PHAT $7.81
  • LVRO $4.50
  • Resistance Level
  • PHAT $8.56
  • LVRO $5.50
  • Average True Range (ATR)
  • PHAT 0.59
  • LVRO 0.31
  • MACD
  • PHAT 0.22
  • LVRO -0.02
  • Stochastic Oscillator
  • PHAT 38.28
  • LVRO 51.00

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: